These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 2845554

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. [Evaluation of ACTH and corticosteroid therapy in multiple sclerosis].
    Hamel-Puskarić N, Arko K, Dupelj M, Novak Z, Barac B, Czukor M.
    Neuropsihijatrija; 1969; 17(1):51-70. PubMed ID: 4191305
    [No Abstract] [Full Text] [Related]

  • 23. Activity of adenosine deaminase in red blood cells of patients suffering from multiple sclerosis treated with adrenocorticotropic hormone.
    Kopff M, Zakrzewska I, Klem J, Puczkowski S, Strzelczyk M, Czernicki J, Chmielewski H.
    Pol J Pharmacol; 1995; 47(6):525-30. PubMed ID: 8868375
    [Abstract] [Full Text] [Related]

  • 24. Adrenocorticotrophic potency of long-acting corticotrophin preparations during long-term treatment of neurological patients.
    Rinne UK.
    Ann Med Intern Fenn; 1968; 57(4):167-72. PubMed ID: 4307479
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Preliminary analysis of a trial of pulse cyclophosphamide in IFN-beta-resistant active MS.
    Smith D.
    J Neurol Sci; 2004 Aug 15; 223(1):73-9. PubMed ID: 15261565
    [Abstract] [Full Text] [Related]

  • 27. [Treatment of rheumatoid arthritis with immunosuppressive agents. Review of literature and personal cases. Results in 45 patients treated with cyclophosphamide for 6 years].
    Frizziero L, Zizzi F, Facchini A, Zini G, Ferruzzi A, Mariani E.
    Recenti Prog Med; 1981 Dec 15; 71(6):612-40. PubMed ID: 7041209
    [No Abstract] [Full Text] [Related]

  • 28. Immunosuppressive treatment of multiple sclerosis.
    Hartshorn JC.
    J Neurosurg Nurs; 1984 Oct 15; 16(5):275-8. PubMed ID: 6094750
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. [Experience using sinakten-retard in the treatment of muscular sclerosis].
    Neretin VIa, Kir'iakov VA, Pegova LN.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1978 Oct 15; 78(4):514-8. PubMed ID: 207061
    [Abstract] [Full Text] [Related]

  • 31. DIAS rounds. Cyclophosphamide in multiple sclerosis.
    Mason G, Hart LL.
    Drug Intell Clin Pharm; 1984 Mar 15; 18(3):215-6. PubMed ID: 6697883
    [No Abstract] [Full Text] [Related]

  • 32. [Clinical picture and treatment of multiple sclerosis].
    Karlov VA, Makarov VA, Seleznev AN, Savina EB.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1983 Mar 15; 83(2):185-9. PubMed ID: 6134408
    [Abstract] [Full Text] [Related]

  • 33. [Critic study of multiple sclerosis treatment by chlorambucil and intraspinal corticotherapy. Apropos of 100 cases followed up from 2 to 9 years].
    Sigwald J, Mazalton A, Raymondeaud C, Piot C, Jacquillat C.
    Rev Neurol (Paris); 1973 Jan 15; 128(1):72-7. PubMed ID: 4367744
    [No Abstract] [Full Text] [Related]

  • 34. Acute improvement in exacerbating multiple sclerosis produced by intravenous administration of mannitol.
    Stefoski D, Davis FA, Schauf CL.
    Ann Neurol; 1985 Oct 15; 18(4):443-50. PubMed ID: 3000278
    [Abstract] [Full Text] [Related]

  • 35. [The therapeutic effect of corticosteroids on the symptoms and course of multiple sclerosis].
    Mayer K, Trübestein G, Diefenbach C.
    Med Welt; 1970 Mar 07; 10():392-5. PubMed ID: 4314318
    [No Abstract] [Full Text] [Related]

  • 36. Medications used in the treatment of multiple sclerosis.
    Schapiro RT.
    Phys Med Rehabil Clin N Am; 1999 May 07; 10(2):437-46, ix. PubMed ID: 10370939
    [Abstract] [Full Text] [Related]

  • 37. Evaluation of the immunosuppressive effects of cyclophosphamide in patients with multiple sclerosis.
    ten Berge RJ, van Walbeek HK, Schellekens PT.
    Clin Exp Immunol; 1982 Dec 07; 50(3):495-502. PubMed ID: 7165996
    [Abstract] [Full Text] [Related]

  • 38. Current methods of therapy in multiple sclerosis.
    Sibley WA.
    Mod Treat; 1970 Sep 07; 7(5):918-29. PubMed ID: 4326377
    [No Abstract] [Full Text] [Related]

  • 39. Plasmapheresis, lymphocytapheresis, and immunosuppressive drug therapy in multiple sclerosis.
    Hauser SL, Fosburg M, Kevy S, Weiner HL.
    Prog Clin Biol Res; 1982 Sep 07; 106():239-54. PubMed ID: 6184727
    [Abstract] [Full Text] [Related]

  • 40. Impairment of the pituitary-adrenal axis following prolonged therapy with corticotrophin.
    Levell MJ, Noronha MJ, Stitch SR.
    Acta Endocrinol (Copenh); 1970 Dec 07; 65(4):608-16. PubMed ID: 4320859
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.